Return
- 1M
- 3M
- 6M
- 1Y
- 3Y
- 5Y
This Fund:
Sensex:
BankFD:
Showing Funds Performance since Sep 07, 2020
Fund Overview
Min. investment
SIP ₹0 & Lump. ₹1000
AUM (Fund size)
₹1,059 Cr
Lock In Period
N/A
Expense Ratio
N/A
Benchmark
Nifty Pharma Total Return
Exit Load
Nil
Summary
Latest details for Nippon India Nifty Pharma ETF Growth include a ₹22.3739 NAV as of Apr 02,2026 and returns since inception of 85.74%. Minimum investments start at SIP ₹0. The Nippon India Nifty Pharma ETF Growth AUM is ₹1,059 Cr, with a lock-in of N/A years, expense ratio of N/A%, and benchmark Nifty Pharma Total Return. Exit load is - Nil. In the growth review for 1M Month/Year, the fund recorded -4.12% returns, against a category average of -2.02% and a category best of 3.73%.
Calculate Returns
You would have got
Your Investment Amount
- 1
- 2
- 3
- 4
- 5
Growth Review
| Duration | Fund Return(%) | Category Average(%) | Category Best(%) |
|---|---|---|---|
| 1M | -4.12 | -2.02 | 3.73 |
| 6M | 1.42 | 0.64 | 66.17 |
| 1Y | 6.49 | 4.39 | 136.30 |
| 3Y | 22.92 | 12.16 | 224.26 |
Portfolio Analysis
- Equity: 99.90%
- Debt: 0.10%
- Others
As on: 2026-02-28
View allocation % by
About Fund
Nippon India Nifty Pharma ETF Growth managed by Nippon India Mutual Fund,is a Equity - Index Fundscheme with Assets Under Management of ₹1,059 Crore. The fund benchmarks its performance against the Nifty Pharma Total Return while maintaining an expense ratio of . Under the expert guidance of Jitendra Tolani ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.
Peer Comparison
| Fund Name | Ratings | AUM | Expense Ratio |
|---|---|---|---|
| This FundKotak Nifty Midcap 50 ETF Growth | 0 | 176.38 CR | 0.05 |
| This FundMotilal Oswal S&P 500 Index Fund Growth | 3 | 4055.83 CR | 1.15 |
| This FundNippon India Nifty Pharma ETF Growth | 0 | 1058.55 CR | |
| This FundKotak Silver ETF Growth | 0 | 4148.21 CR | 0.45 |
| This FundICICI Prudential Silver ETF Growth | 0 | 16848.3 CR | 0.4 |
| Fund Name | 1Y | 3Y |
|---|---|---|
| This FundKotak Nifty Midcap 50 ETF Growth | 6.5806 | 83.0506 |
| This FundMotilal Oswal S&P 500 Index Fund Growth | 26.9299 | 83.221 |
| This FundNippon India Nifty Pharma ETF Growth | 6.4926 | 85.7365 |
| This FundKotak Silver ETF Growth | 135.6624 | 223.8757 |
| This FundICICI Prudential Silver ETF Growth | 135.3354 | 224.256 |
FAQs
Nippon India Nifty Pharma ETF Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.
The expense ratio of Nippon India Nifty Pharma ETF Growth is . This expense ratio is calculated by dividing the fund's operating expenses by its net assets.
Nippon India Nifty Pharma ETF Growth’s fund performance is as follows:
- 1 Month : -4.12%
- 6 Months : 1.42%
- 1 Year : 6.49%
- 3 Years : 22.92%
You can invest in Nippon India Nifty Pharma ETF Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.
The fund size (AUM) of Nippon India Nifty Pharma ETF Growth is ₹1,059 crore. It changes based on market performance, inflows, and outflows.
You can track your investment in Nippon India Nifty Pharma ETF Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.
Min Inv Amount: ₹500